The stock's rise snapped a four-day losing streak.

This was the stock's fourth consecutive day of losses.

UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal ...

Amedisys is a main competitor in many markets to LHC Group, which UnitedHealth purchased last year. Attorneys general of ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

U.S. senators and other lawmakers argue the problems created by UnitedHealth's size and reach demand steps to restore public ...

UnitedHealth Group is a proven market-beater with clean ... its gravest threat isn't competition -- it's its regulators. Healthcare is highly political due to its importance and steadily rising ...

Amedisys and UnitedHealth extend their $3.3B merger deadline to 2025, amid DOJ scrutiny over competition concerns in the home ...

UnitedHealth Group has filed for more time to complete a $3.3 billion deal to buy Amedisys, a home health care and hospice ...

Shares of what may be America's most powerful healthcare company have declined due to controversy and regulatory threats.